WHWK
WHWK
NASDAQ · Biotechnology

Whitehawk Therapeutics Inc

$3.21
-0.03 (-0.93%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 10 71%
Hold 4 29%
Sell 0 0%
Price Target
Analyst Price Target +439.3% upside
Low Target $14.24
Average Target $17.31
High Target $28.90
Current Price $3.21
Current
$3.21
Target
$17.31
$14.24 $17.31 avg $28.90
Scenario Analysis
Bear Case
$14.24
343.6%
Low target
Base Case
$17.31
+439.3%
Avg target
Bull Case
$28.90
+800.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.50
-41.6% from high
52-Week Low
$1.97
+62.9% from low
Target vs 52W High
$17.31
+215.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%